Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 47.77B | 51.45B | 49.48B | 41.88B | 38.67B | 34.71B |
Gross Profit | 6.34B | 6.62B | 6.62B | 5.46B | 5.83B | 3.72B |
EBITDA | 5.99B | 6.68B | 7.06B | 6.29B | 6.77B | 6.08B |
Net Income | 727.90M | 630.21M | 601.01M | 391.87M | 644.64M | 670.38M |
Balance Sheet | ||||||
Total Assets | 65.82B | 66.61B | 62.98B | 56.91B | 54.75B | 54.13B |
Cash, Cash Equivalents and Short-Term Investments | 8.42B | 9.27B | 9.07B | 6.83B | 6.31B | 6.00B |
Total Debt | 12.11B | 12.01B | 9.72B | 10.31B | 10.90B | 12.70B |
Total Liabilities | 29.32B | 28.57B | 25.94B | 23.93B | 23.33B | 24.50B |
Stockholders Equity | 27.92B | 29.03B | 28.47B | 24.95B | 23.93B | 22.58B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.24B | 3.61B | 2.25B | 3.53B | 1.23B |
Operating Cash Flow | 0.00 | 4.30B | 6.96B | 4.80B | 6.88B | 5.44B |
Investing Cash Flow | 0.00 | -3.77B | -3.34B | -2.53B | -3.54B | -2.58B |
Financing Cash Flow | 0.00 | -864.98M | -1.91B | -2.20B | -3.30B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥10.66B | 16.89 | 3.24% | 3.98% | 4.62% | ||
75 Outperform | ¥9.29B | 3.15 | 2.69% | 2.17% | 66.19% | ||
73 Outperform | ¥8.56B | 6.87 | 3.53% | 8.63% | 9.65% | ||
70 Outperform | ¥8.68B | 6.09 | 7.10% | 0.69% | 7.21% | ||
56 Neutral | HK$23.71B | 3.90 | -1.57% | 6.72% | 0.06% | -64.88% | |
56 Neutral | ¥8.26B | ― | 2.75% | -3.96% | -462.50% | ||
39 Underperform | ¥3.56B | ― | ― | 33.86% | 69.12% |